Cargando…

Fibroblast Growth Factor Receptor 4 Targeting in Cancer: New Insights into Mechanisms and Therapeutic Strategies †

Fibroblast growth factor receptor 4 (FGFR4), a tyrosine kinase receptor for FGFs, is involved in diverse cellular processes, including the regulation of cell proliferation, differentiation, migration, metabolism, and bile acid biosynthesis. High activation of FGFR4 is strongly associated with the am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lang, Liwei, Teng, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356571/ https://www.ncbi.nlm.nih.gov/pubmed/30634399 http://dx.doi.org/10.3390/cells8010031

Ejemplares similares

Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer
por: Inokuchi, Mikito, et al.
Publicado: (2015)

Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance
por: Krook, Melanie A., et al.
Publicado: (2020)

Mechanisms of acquired resistance to fibroblast growth factor receptor targeted therapy
por: Lau, David K., et al.
Publicado: (2019)

Fibroblast growth factor receptor signaling as therapeutic targets in female reproductive system cancers
por: Zhu, Dong-Li, et al.
Publicado: (2020)

Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma
por: Narisawa, Takafumi, et al.
Publicado: (2023)

Targeting Cellular Trafficking of Fibroblast Growth Factor Receptors as a Strategy for Selective Cancer Treatment
por: Porębska, Natalia, et al.
Publicado: (2018)

Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics
por: Lang, Liwei, et al.
Publicado: (2017)

Role of fibroblast growth factor receptor 4 in cancer
por: Tang, Shuya, et al.
Publicado: (2018)

mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma
por: Scheller, T, et al.
Publicado: (2015)

Fibroblast Growth Factor Receptors as Novel Therapeutic Targets in SNF5-Deleted Malignant Rhabdoid Tumors
por: Wöhrle, Simon, et al.
Publicado: (2013)

Targeting fibroblast growth factor receptors to combat aggressive ependymoma
por: Lötsch, Daniela, et al.
Publicado: (2021)

Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy
por: Szlachcic, Anna, et al.
Publicado: (2016)

Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer
por: Turkington, R C, et al.
Publicado: (2014)

Fibroblast growth factors as tissue repair and regeneration therapeutics
por: Nunes, Quentin M., et al.
Publicado: (2016)

New Therapeutic Strategies for Osteoarthritis by Targeting Sialic Acid Receptors
por: Carpintero-Fernandez, Paula, et al.
Publicado: (2020)

Fibroblast Growth Factor Receptors-1 and -3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting
por: Cheng, Tiewei, et al.
Publicado: (2013)

Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer
por: Jain, Vikram K, et al.
Publicado: (2012)

Rationale for targeting fibroblast growth factor receptor signaling in breast cancer
por: André, Fabrice, et al.
Publicado: (2015)

Construction and characterization of immunoliposomes targeting fibroblast growth factor receptor 3
por: Zheng, Zhong, et al.
Publicado: (2019)

Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer
por: Pacini, Laura, et al.
Publicado: (2021)

Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer
por: Francavilla, Chiara, et al.
Publicado: (2022)

Fast Growing Furious Races for Targeting Fibroblast Growth Factor Receptors
por: Park, Daechan
Publicado: (2022)

Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies
por: Nadhan, Revathy, et al.
Publicado: (2023)

Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland
por: Doddapaneni, Ravi, et al.
Publicado: (2019)

Targeting Vascular Endothelial Growth Factor Receptors as a Therapeutic Strategy for Osteoarthritis and Associated Pain
por: Ma, Kaige, et al.
Publicado: (2023)

Therapeutic effects of thalidomide in myeloma are associated with the expression of fibroblast growth factor receptor 3
por: Qian, Shenxian, et al.
Publicado: (2005)

Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival
por: Tiong, Kai Hung, et al.
Publicado: (2016)

An insight into the possibilities of fibroblast growth factor in periodontal regeneration
por: Nath, Sameera G., et al.
Publicado: (2014)

Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies
por: Zarantonello, Alessandra, et al.
Publicado: (2021)

New Insights into the Functions of MicroRNAs in Cardiac Fibrosis: From Mechanisms to Therapeutic Strategies
por: Zhao, Yuanyuan, et al.
Publicado: (2022)

Targeting fibroblast growth factors in cancer
por: Baker, Kevin P., et al.
Publicado: (2013)

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
por: Sobhani, Navid, et al.
Publicado: (2018)

Importance of Translational Research for Targeting Fibroblast Growth Factor Receptor Signaling in Cancer
por: Holzmann, Klaus, et al.
Publicado: (2019)

Fibroblast growth factor receptors as targets for anticancer therapy in cholangiocarcinomas and urothelial carcinomas
por: Wekking, Demi, et al.
Publicado: (2023)

Trends in insulin resistance: insights into mechanisms and therapeutic strategy
por: Li, Mengwei, et al.
Publicado: (2022)

Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention
por: Jin, Dian, et al.
Publicado: (2023)

Fibroblast Growth Factor Receptor 4 Polymorphism Is Associated with Liver Cirrhosis in Hepatocarcinoma
por: Sheu, Ming-Jen, et al.
Publicado: (2015)

Novel molecular insights and new therapeutic strategies in osteosarcoma
por: Otoukesh, Babak, et al.
Publicado: (2018)

Wolfram syndrome: new pathophysiological insights and therapeutic strategies
por: Mishra, Ratnakar, et al.
Publicado: (2021)

Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis
por: Tan, Yossan-Var, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lrpg44bn25p3i1oltk24f35vnu